Prevalence of hepatitis viruses among chronic renal failure patients on hemodialysis in central India

Dialysis and Transplantation

Volumn 31, Issue 4, 2002, Pages 234-240

  Jaiswal, ShreePrakash B ^a   Chitnis, Dhananjay S ^a   Salgia, Pradeep ^a   Sepaha, Achal ^a  

^a CHOITHRAM HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS C ANTIBODY; HEPATITIS E ANTIGEN; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ANTIGEN DETECTION; BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; DELTA AGENT HEPATITIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HYGIENE; IMMUNE DEFICIENCY; INDIA; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SUPERINFECTION; VACCINATION; VIRUS TRANSMISSION;

EID: 0036221126     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Active hepatitis B vaccination of dialysis patients and medical staff
2. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infections among hemodialysis and CAPD patients: Evidence for environmental transmission
3. Hepatitis in patients with end-stage renal disease
4. Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: Back to basics
5. Dialysis therapy: Past, present and future
6. Hepatitis and HIV infection during hemodialysis
7. Hepatitis B antigen in patients and staff of dialysis units in Bombay
8. Hepatitis B infection in a dialysis unit in South India
9. A study of hepatitis B surface antigen positive patients on hemodialysis and following transplantation
10. Hepatitis B in a hemodialysis unit in New Delhi
11. HBV infection in patients with chronic renal failure on repeated hemodialysis
12. Nosocomial hepatitis C in dialysis units
13. National surveillance of dialysis-associated diseases in the United States
14. Prevalence of antibodies to hepatitis C virus in HBsAg negative hemodialysis patients
15. Prevalence of hepatitis B and C virus infections in hemodialysis patients in Pune (Western India)
16. Prevalence of hepatitis C virus infection in liver diseases, renal disease, and voluntary blood donors in South India
17. Should we dialyse all hepatitis C positive patients on dedicated machines?
18. Prevalence of anti-HCV antibodies in Central India
19. Prevalence of anti-HCV antibodies in Western India
20. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients, with possible routes of transmission
21. Multicentric study of hepatitis C virus infections in chronic hemodialysis patients and hemodialysis center staff members
22. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in hemodialysis patients
23. Antibody to hepatitis C virus increases with time on hemodialysis
24. Hepatitis C in the hemodialysis setting: A review with recommendations for control
25. Hepatitis C virus infection in hemodialysis patients in Southern Sweden: Epidemiological, clinical and diagnostic aspects
26. Hepatitis C infection unrelated to blood transfusion
27. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV
28. Low prevalence of hepatitis D (delta) virus infection in a nephrology unit in South India
29. Prevalence of anti-delta antibodies in Central India and comparison of data from other parts of India